FDA Launches Searchable Adverse Event Database for Drugs and Biologics
By Michael Mezher -
Published 29 September 2017
The US Food and Drug Administration (FDA) on Wednesday launched a new searchable public dashboard for its adverse event database for drugs and biologics.
Categories: News, US, FDA, Biologics and biotechnology, Drugs, Postmarket surveillance
Tags: FAERS, Public Dashboard, Adverse Event Reports